| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2121621 | European Journal of Cancer | 2015 | 8 Pages | 
Abstract
												High volume of SAT is independently associated with overall survival in mCRPC patients treated with next generation AR axis inhibitors.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Sami Antoun, Amine Bayar, Ekatarina Ileana, Agnès Laplanche, Karim Fizazi, Mario di Palma, Bernard Escudier, Laurence Albiges, Christophe Massard, Yohann Loriot, 
											